Volume 19, Issue 103 (1-2013)                   RJMS 2013, 19(103): 33-40 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Khoshpey B, Shidfar F, Jazayeri S, Malek M, Hosseini A F. Effect of royal jelly intake on serum glucose, HbA1c, and total antioxidant capacity (TAC) in type 2 diabetic patients: a randomized, double blind clinical trial study. RJMS 2013; 19 (103) :33-40
URL: http://rjms.iums.ac.ir/article-1-2347-en.html
Tehran University of Medical Sciences
Abstract:   (7350 Views)

  Background : Type 2 diabetes melitus (DM) is highly prevalent worldwide. Evidence supports a role for royal jelly in reduction of serum glucose and lipids. The purpose of this study was to determine the effects of royal jelly intake on serum glucose, HbA1c, and Total Antioxidant Capacity (TAC) in type 2 diabetic patients.

  Methods: Fifty patients with type 2 DM participated in a double-blind, placebo-controlled, 8-weeks study. The patients with type 2 DM were divided randomly into placebo and royal jelly groups of 25 each. Both groups received the treatment for 8 weeks. In royal jelly group participants received three 1000 mg royal jelly capsules daily and placebo group received three 1000 mg placebo capsules daily. Blood samples were taken after 12 hours of fasting at the beginning and the end of the study. Serum glucose, HbA1c, and TAC were evaluated.

  Results: Forty six participants completed the study. Royal jelly intake reduced FBS levels (p=0.006) and increased TAC (p=0.016) significantly after 8 weeks compared with placebo. Royal jelly did not affect serum HbA1c levels.

  Conclusion : This study shows that royal jelly has some benefits in type 2 diabetic patients.

Full-Text [PDF 325 kb]   (2549 Downloads)    
Type of Study: Research | Subject: Nutrition Sciences

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Razi Journal of Medical Sciences

Designed & Developed by : Yektaweb